Comparison of Qigong and Otago in Patient With Diabetic Neuropathy
ConditionDiabetic Neuropathies
Trial statusNot yet recruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age45-65
SponsorRiphah International University
About this trial
This study seeks to compare these two interventions to better understand their impact on key health outcomes in patients affected by diabetic neuropathy, providing valuable insights for clinicians and healthcare providers managing this challenging condition
Eligibility criteria
Qualifiers
Physician-diagnosed type 2 diabetes without gender bias, with peripheral neuropathy (defined by Michigan Neuropathy Screening Instrument questionnaire score of 5 or greater)
Type 2 diabetic peripheral neuropathy patients
The ability to walk independently for 10 m
Having score between 46 to 52 (out of a total of 56 points) on the BBS
Disqualifiers
Fracture of the lower limb within the 6 months before the study (15)
Diabetic ulcer, infection or partial amputation in feet (15)
Disease or functional impairment of auditory, vestibular system (16)
Any other medical conditions that would confound assessment of neuropathy such as malignancy, other neurological or orthopedic impairments (such as stroke, poliomyelitis, rheumatoid arthritis, prosthesis, or severe osteoarthritis), major vascular complications (venous or arterial ulcers), severe retinopathy, or severe nephropathy that causes edema or needs hemodialysis (17)
Trial design
Treatments tested in this trial
- Qigong Balance
- Otago Balance
Treatment groups
44 Participants
are divided into 2 treatment groupsSponsors and collaborators
Source ClinicalTrials.gov